| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "[Cyclosporine co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of COL6A3 mRNA | 19933214 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA" | 25510870 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL6A3 mRNA" | 25614096 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA" | 25510870 |
| C035208 | 2-amino-4,6-dinitrotoluene | "2-amino-4,6-dinitrotoluene results in decreased expression of COL6A3 mRNA" | 26251320 |
| C583074 | 4,4'-hexafluorisopropylidene diphenol | "4,4'-hexafluorisopropylidene diphenol results in decreased expression of COL6A3 mRNA" | 25912373 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of COL6A3 mRNA | 21420995 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of COL6A3 mRNA | 17562736 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of COL6A3 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of COL6A3 gene | 27153756 |
| D001151 | Arsenic | Arsenic affects the methylation of COL6A3 gene | 25304211 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of COL6A3 mRNA | 20458559 |
| D001374 | Azacitidine | Azacitidine results in decreased expression of COL6A3 mRNA | 20823114 |
| C547126 | AZM551248 | AZM551248 results in increased expression of COL6A3 mRNA | 22323515 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of COL6A3 mRNA | 20713471 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of COL6A3 mRNA | 22300585 |
| D004958 | Estradiol | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A3 mRNA | 20823114 |
| D004958 | Estradiol | Estradiol affects the expression of COL6A3 protein | 20864640 |
| D004958 | Estradiol | Estradiol results in increased expression of COL6A3 mRNA | 15289156 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of COL6A3 mRNA | 25912373 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of COL6A3 protein | 28273538 |
| C006780 | bisphenol A | bisphenol A results in increased expression of COL6A3 mRNA | 27685785 |
| C006780 | bisphenol A | bisphenol A affects the expression of COL6A3 mRNA | 25181051 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of COL6A3 mRNA | 18958704 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL6A3 mRNA | 22079614 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of COL6A3 mRNA | 17484886 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A3 mRNA | 20938992 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of COL6A3 mRNA | 22300585 |
| D016572 | Cyclosporine | "[Cyclosporine co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone] | 18435905 |
| D016572 | Cyclosporine | Cyclosporine results in increased methylation of COL6A3 promoter | 27989131 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of COL6A3 mRNA | 21198554 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of COL6A3 mRNA | 25047013 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA | 16054899 |
| D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA] | 16054899 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of COL6A3 mRNA | 20032058 |
| D003907 | Dexamethasone | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL6A3 mRNA] | 20032058 |
| D003994 | Bucladesine | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A3 mRNA | 20823114 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of COL6A3 mRNA | 26924002 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of COL6A3 mRNA | 18042831 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of COL6A3 mRNA | 15289156 |
| D004237 | Diuron | Diuron results in increased expression of COL6A3 mRNA | 21551480 |
| D004317 | Doxorubicin | COL6A3 protein affects the susceptibility to Doxorubicin | 16217747 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of COL6A3 mRNA | 15033991 |
| D004533 | Egtazic Acid | "[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| D004533 | Egtazic Acid | "[Cyclosporine co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| C118739 | entinostat | entinostat results in increased expression of COL6A3 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of COL6A3 mRNA | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of COL6A3 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A3 mRNA | 17942748 |
| C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of COL6A3 mRNA | 28189721 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of COL6A3 mRNA | 23649840 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased mutagenesis of COL6A3 mRNA | 27776689 |
| D005472 | Fluorouracil | COL6A3 protein affects the susceptibility to Fluorouracil | 16217747 |
| D005472 | Fluorouracil | TP53 protein affects the reaction [Fluorouracil results in decreased expression of COL6A3 mRNA] | 15016801 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A3 mRNA | 20938992 |
| D004397 | Fonofos | Fonofos results in increased methylation of COL6A3 promoter | 22847954 |
| D019833 | Genistein | Genistein results in increased expression of COL6A3 mRNA | 15289156 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of COL6A3 mRNA | 28973697 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA] | 16054899 |
| D007529 | Isoflavones | Isoflavones affects the expression of COL6A3 mRNA | 16365062 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of COL6A3 mRNA | 24796395 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of COL6A3 mRNA | 26644586 |
| D017258 | Medroxyprogesterone Acetate | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A3 mRNA | 20823114 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL6A3 mRNA | 20938992 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of COL6A3 mRNA | 23649840 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of COL6A3 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of COL6A3 mRNA" | 25554681 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of COL6A3 mRNA | 16166746 |
| D009840 | Oligomycins | COL6A3 gene mutant form results in increased susceptibility to Oligomycins | 18435905 |
| D017239 | Paclitaxel | COL6A3 protein affects the susceptibility to Paclitaxel | 16217747 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of COL6A3 mRNA | 18042831 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of COL6A3 mRNA | 26272509 |
| D010278 | Parathion | Parathion results in increased methylation of COL6A3 promoter | 22847954 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of COL6A3 mRNA" | 25510870 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of COL6A3 mRNA | 19162173 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of COL6A3 mRNA | 26272509 |
| D010672 | Phenytoin | Phenytoin results in increased expression of COL6A3 mRNA | 8224229 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of COL6A3 mRNA | 17426115 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of COL6A3 mRNA | 23608068 |
| D011374 | Progesterone | Progesterone results in decreased expression of COL6A3 mRNA | 23012394 |
| D011374 | Progesterone | Progesterone affects the expression of COL6A3 protein | 20864640 |
| D011794 | Quercetin | Quercetin results in increased expression of COL6A3 mRNA | 16455785 |
| C059514 | resveratrol | resveratrol results in decreased expression of COL6A3 mRNA | 19228061 |
| D015474 | Isotretinoin | Isotretinoin results in increased expression of COL6A3 mRNA | 20436886 |
| C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA | 16054899 |
| C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA] | 16054899 |
| D012402 | Rotenone | "[1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| D012402 | Rotenone | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| D012402 | Rotenone | COL6A3 gene mutant form results in increased susceptibility to Rotenone | 18435905 |
| D012402 | Rotenone | "[Cyclosporine co-treated with 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester co-treated with Egtazic Acid] inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone]" | 18435905 |
| D012402 | Rotenone | Cyclosporine inhibits the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone] | 18435905 |
| D012402 | Rotenone | Thapsigargin promotes the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone] | 18435905 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of COL6A3 mRNA | 18812580 |
| D012999 | Soman | Soman results in increased expression of COL6A3 mRNA | 19281266 |
| D013311 | Streptozocin | Streptozocin results in increased expression of COL6A3 protein | 19634143 |
| D013311 | Streptozocin | Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A3 protein] | 19634143 |
| D013467 | Sulindac | Sulindac results in increased expression of COL6A3 mRNA | 18499699 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of COL6A3 mRNA | 15507505 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of COL6A3 mRNA | 14699072 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of COL6A3 mRNA | 17555576 |
| C012568 | terbufos | terbufos results in increased methylation of COL6A3 promoter | 22847954 |
| D013739 | Testosterone | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL6A3 mRNA] | 20032058 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of COL6A3 mRNA | 26377647 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A3 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA] | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of COL6A3 mRNA] | 15667827 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of COL6A3 mRNA | 16922920|1993321 |
| D019284 | Thapsigargin | Thapsigargin promotes the reaction [COL6A3 gene mutant form results in increased susceptibility to Rotenone] | 18435905 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of COL6A3 mRNA | 28111298 |
| C011559 | tributyltin | tributyltin results in increased expression of COL6A3 mRNA | 21683754 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of COL6A3 mRNA | 26272509 |
| D014266 | Trientine | Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A3 protein] | 19634143 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A3 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of COL6A3 mRNA | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of COL6A3 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of COL6A3 mRNA | 24896083 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of COL6A3 mRNA | 18930951 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of COL6A3 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of COL6A3 mRNA | 19015723 |
| D014810 | Vitamin E | Vitamin E results in increased expression of COL6A3 mRNA | 19244175 |
| C111237 | vorinostat | vorinostat results in increased expression of COL6A3 mRNA | 26272509 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in decreased expression of COL6A3 mRNA | 27215404 |